日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Overcoming T cell tolerance to tumor self-antigens through catch-bond engineering

通过捕获键工程克服T细胞对肿瘤自身抗原的耐受性

Chen, Xiaojing; Mao, Zhiyuan; Kolawole, E Motunrayo; Persechino, Margherita; Jude, Kevin M; Ogishi, Masato; Mo, Kelvin C; McLaughlin, Jami; Cheng, Donghui; Xiang, Xinyu; Yang, Xinbo; Gee, Caitlin; Liu, Shiqin; Yang, Aerin; Obenaus, Matthias; Wang, Nan; Noguchi, Miyako; Stoyanova, Tanya; Lee, John K; Good, Zinaida; Latorraca, Naomi R; Evavold, Brian D; Witte, Owen N; Garcia, K Christopher

Demographics, Services, and Practices in Attention-Deficit/Hyperactivity Disorder Coaching in the US

美国注意力缺陷/多动障碍辅导的人口统计、服务和实践

Sibley, Margaret H; Graham, Elias D; Holbrook, Jillian K; Dvorsky, Melissa R; Yeguez, Carlos E; Rosier, Tamara; Coghill, David; Page, Timothy F; Fouche, Roxanne; Demuth, Jami

Synthetic lethality between RB-loss and E2F3 inhibition in small cell cancers targeted by pyrimidine synthesis blockade

嘧啶合成阻断靶向的小细胞癌中RB缺失与E2F3抑制之间的合成致死性

Abt, Evan R; Wang, Liang; Varuzhanyan, Grigor; Freeland, Jack; He, Tian; Peña-Garcia, Guadalupe M; Ruegg, Lauryn; McLaughlin, Jami; Cheng, Donghui; Balanis, Nikolas G; Chen, Chia-Chun; Xu, Yang; Xing, Yi; Memarzadeh, Sanaz; Radu, Caius G; Graeber, Thomas G; Witte, Owen N

Reconsidering the definition of triple-negative breast cancer in the immune checkpoint inhibitor era: an optimal cut-off value for hormone receptor percentage of HER2-negative invasive breast cancer

重新审视免疫检查点抑制剂时代三阴性乳腺癌的定义:HER2阴性浸润性乳腺癌激素受体百分比的最佳临界值

Fujii, Takeo; Iwase, Toshiaki; Shen, Yu; Fukui, Jami; Ueno, Naoto T

Cord Blood DNA Methylation at CHD13 Is Associated with Adiponectin Levels at 10 to 14 Years of Age

脐带血中CHD13位点的DNA甲基化与10至14岁时的脂联素水平相关

Bianco, Monica E; Gurra, Miranda G; Scholtens, Denise M; Hivert, Marie-France; Lowe, William L Jr; Josefson, Jami L

Beyond the 'Go-Live': why context matters in EHR implementations

超越“上线”:为什么电子病历实施中的背景至关重要

Chih, Ming-Yuan; Warren, Jami L; Iqbal, Usman; Sholokhova, Kseniia; Li, Yu-Chuan Jack

The Excelsatoxin A-Receptor TMEM233 Modulates Nav1.8

Excelsatoxin A 受体 TMEM233 调节 Nav1.8

Oprita, George; Meyer, Marvin J A; Rudolf, Daniel; Pombeiro Stein, Inês C A; Deuis, Jennifer R; Tran, Hue N T; Durek, Thomas; Tabea, Klasfauseweh; Sina, Jami; Waxman, Stephen G; Dib-Hajj, Sulayman D; Babes, Alexandru; Vetter, Irina; Leffler, Andreas

Unveiling the anti-inflammatory activity of chloroform fraction of curcuma wallichii and its phytoconstituents by in vivo and in silico studies

通过体内和计算机模拟研究揭示姜黄氯仿提取物及其植物成分的抗炎活性

Hossain, Md Sabbir; Jami, Md Abu Bakar Siddique; Ashraful, Abm; Uddin, Md Najem; Sarker, Joy; Uddin, Md Josim; Sadik, Md Golam; Alam, Ahm Khurshid

Navigating Non-interventional Post-authorization Studies in East Asia: Regulatory Challenges, Opportunities, and Future Directions

东亚地区非干预性上市后研究的监管挑战、机遇与未来方向

Peters, Jami; Ali, Ayad K; Moitinho de Almeida, Maria; Asao, Keiko; Hammad, Tarek A; He, Xintong; Michel, Alexander; Rubino, Annalisa; Sawada, Sono; Sobel, Rachel E; de Vogel, Stefan

Progesterone receptor membrane component 1 (PGRMC1) regulates Heme trafficking through mitochondria-ER junctions

孕酮受体膜组分1(PGRMC1)调节血红素通过线粒体-内质网连接的运输

Piel Iii, Robert B; Obi, Chibuike D; Viana, Martonio Ponte; Willoughby, Mathilda M; Martinez-Guzman, Osiris; Wadley, Aaliyah; Jami-Alahmadi, Yasaman; Wohlschlegel, James A; Hicks, Kevin G; Rutter, Jared; Maschek, J Alan; Catrow, J Leon; Cox, James; Reddi, Amit R; Khalimonchuk, Oleh; Medlock, Amy E